From: Multilevel approaches to address disparities in lung cancer screening: a study protocol
 | T0 | T1 | T2 | |
---|---|---|---|---|
 | Baseline | 1 week | 6 months | |
Patient-level variables | Primary outcomes: Provider-patient discussion, lung screening intentions, screening knowledge | X | X | Â |
Secondary outcomes: Lung screening referrals, completion rates (EHR) | X | Â | X | |
Moderators: Race, smoking status, health literacy | X | Â | Â | |
Intervention targets: Physician–patient communication, perceived risk, self-efficacy, benefits/barriers, patient activation, attended visit/visit type | X | X |  | |
Covariates: Demographics, social determinants of health, tobacco behaviors, cancer screening history, psychological variables (e.g., stigma, medical mistrust) | X | Â | Â | |
Provider-level variables | Demographics | X | Â | Â |
Lung screening practices | X | Â | X | |
Lung screening attitudes | X | Â | X | |
Intervention acceptability, usability, intervention, effectiveness | Â | Â | X | |
Implementation variables | Reach: % of patients offered trial enrollment and the % enrolled out of the number of eligible patients who had a visit during the recruitment period | Pre-post implementation | ||
 | Effectiveness: screening referrals and screening completion rates | |||
 | Adoption: % of messages opened by the receiving provider; fidelity of the patient component | |||
 | Implementation: feasibility, acceptability |